SCHEMBL21844850

SCHEMBL21844850

COCCN(C)CCc1cccc(C(=O)Nc2cc(F)c(C)c(F)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ THRB P10828 1/20 0.41
▸ ROCK2 O75116 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MCHR1 Q99705 2/20 0.39
▸ CYP4F2 P78329 1/20 0.39
▸ CYP4A11 Q02928 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20083999 0.94 KDR (0.43) KDRLMNAMEN1KMT2ATHRB
SCHEMBL20083950 0.87 KDR (0.46) KDRLMNAMEN1KMT2ATHRB
SCHEMBL21844896 0.82 PARP1 (0.49) KDRLMNAMEN1KMT2AROCK2
SCHEMBL21844897 0.77 NPC1 (0.51) LMNAMEN1KMT2ANPC1TP53
SCHEMBL20083997 0.76 NPC1 (0.53) LMNAMEN1KMT2AKDM4ENPC1
SCHEMBL19157203 0.74 KDR (0.46) KDRLMNAMEN1KMT2AROCK2
SCHEMBL21844862 0.74 MEN1 (0.59) LMNAMEN1KMT2ATHRBKDM4E
SCHEMBL20084035 0.73 KCNK3 (0.69) MEN1KMT2ATHRBNPC1TP53
SCHEMBL20083991 0.72 GRM4 (0.46) KDRLMNAMEN1KMT2AROCK2
SCHEMBL15276968 0.71 LMNA (0.52) KDRLMNAMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
Send feedback